Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Farmers Insurance
Citi
Harvard Business School
Merck
Chubb
Queensland Health
Daiichi Sankyo
Deloitte

Generated: April 26, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: insulin human

« Back to Dashboard

insulin human

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Lilly HUMULIN R insulin human SOLUTION;SUBCUTANEOUS 018780 NDA Eli Lilly and Company N 0002-8215-01
Lilly HUMULIN R insulin human SOLUTION;SUBCUTANEOUS 018780 NDA Eli Lilly and Company N 0002-8215-17
Lilly HUMULIN R insulin human SOLUTION;SUBCUTANEOUS 018780 NDA Eli Lilly and Company N 0002-8215-99
Lilly HUMULIN R insulin human SOLUTION;SUBCUTANEOUS 018780 NDA Eli Lilly and Company N 0002-8501-01
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Cipla
McKesson
Harvard Business School
Farmers Insurance
Boehringer Ingelheim
Queensland Health
Chubb
McKinsey